Gilead Sciences, Inc. (GILD)

Last Closing Price: 138.99 (2026-04-10)

Cash Flow from Operating Activities (Annual)

Cash Flow from Operating Activities: A company's cash flows from operations.

Gilead Sciences, Inc. (GILD) had Cash Flow from Operating Activities of $10.02B for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$29.44B
$8.51B
$6.23B
$23.21B
$19.42B
$10.02B
$-226.00M
$9.80B
$9.80B
$8.51B
$8.51B
$8.51B
$8.51B
$10.02B
$12.78B
1.24B
1.25B
$6.84
$6.78
Balance Sheet Financials
$18.34B
$5.61B
$40.68B
$59.02B
$11.81B
$22.13B
$24.59B
$36.41B
$22.62B
$-2.67B
$22.62B
1.24B
Cash Flow Statement Financials
Cash Flow from Operating Activities
$10.02B
$-4.79B
$-7.75B
$9.99B
$7.56B
$-2.43B
$894.00M
$-4.00B
--
Fundamental Metrics & Ratios
1.55
--
--
0.49
1.10
78.83%
34.04%
34.04%
43.41%
33.27%
28.90%
$9.46B
--
--
--
0.50
3.51
5.99
60.91
37.62%
-318.25%
14.42%
19.02%
$18.23
$7.53
$7.98